Not sure if he has the reputation left to get investors, plus there is a lot of baggage, ie Standard Bank loan, complicated share structure (WCC/FSE) Be an interesting few weeks to see what his ideas are.
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status